<DOC>
	<DOCNO>NCT00685269</DOCNO>
	<brief_summary>The purpose study evaluate hypnotic efficacy ezopiclone subject mild moderate OSAS .</brief_summary>
	<brief_title>Safety Efficacy Eszopiclone With Mild Moderate Obstructive Sleep Apnea Syndrome ( OSAS )</brief_title>
	<detailed_description>Sleep apnea sleep disorder characterize pause breathe sleep . This study compare use eszopiclone placebo subject mild moderate obstructive sleep Apnea syndrome ( OSAS ) . Frequency duration apnea hypopnea episode , oxygen saturation , objective sleep parameter safety information collect study . This study previously post Sepracor Inc . In October 2009 , Sepracor Inc. acquire Dainippon Sumitomo Pharma. , October 2010 , Sepracor Inc 's name change Sunovion Pharmaceuticals Inc .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Eszopiclone</mesh_term>
	<criteria>The subject capable understanding comply protocol sign informed consent document , include privacy authorization . Female subject childbearing potential must sign Women Childbearing Potential Addendum inform consent form . Male female subject 35 64 year age , inclusive , mild moderate obstructive sleep apnea syndrome ( AHI range ≥10 ≤40 ) . Females consider childbearing potential must surgically sterile great oneyear post menopausal , define complete cessation menstruation least one year . Subjects must use continuous positive airway pressure ( CPAP ) . Subjects must general good health base screen physical examination ( defined absence clinically relevant abnormality ) , medical history , 12lead ECG , clinical laboratory value ( hematology , serum chemistry urinalysis ) . Subject clinically significant unstable medical abnormality , chronic disease , history clinically significant abnormality cardiovascular , respiratory , hepatic , renal system . Subject history , current malignancy except non melanomatous skin cancer . Subject test positive screen hepatitis B surface antigen hepatitis C antibody , subject history positive result . Subject know seropositive human immunodeficiency virus ( HIV ) .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Obstructive Sleep Apnea Syndrome</keyword>
	<keyword>OSAS</keyword>
</DOC>